Clinical trial
Circulating " Cancer Cells / Macrophage " HYbrid Cells in Patients With Sarcoma?
NCT04512495 is registered in ClinicalTrials.gov with Institut Claudius Regaud as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Circulating " Cancer Cells / Macrophage " HYbrid Cells in Patients With Sarcoma?
- Lead sponsor
- Institut Claudius Regaud
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 22, 2020
- Completion date
- December 2, 2021
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.